Last reviewed · How we verify
NCT03530969
Geriatric Communication Skills Training Program for Oncology Clinicians
NA trial testing Self-Efficacy Assessment in GI Cancer in 88 participants. Completed in 16 February 2024.
16 February 2024
Quick facts
| Lead sponsor | Memorial Sloan Kettering Cancer Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 88 |
| Start date | 7 May 2018 |
| Primary completion | 16 February 2024 |
| Estimated completion | 16 February 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Self-Efficacy Assessment
- UCLA Geriatrics Attitudes Scale
- Course Evaluations
- The Consultation and Relational Empathy (CARE) questionnaire
- Consumer Assessment of Health Care Providers and Systems Program (CAHPS)
- Patient activation measure (PAM) scale
Conditions studied
- GI Cancer — all drugs for GI Cancer →
- Lymphoma — all drugs for Lymphoma →
- GU Cancer — all drugs for GU Cancer →
- Bone Marrow Transplant — all drugs for Bone Marrow Transplant →
Sponsor
Memorial Sloan Kettering Cancer Center — full company profile →
Who can join
18 and older, any sex, with GI Cancer or Lymphoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to learn more about the effects of a training program designed to help doctors communicate better with older patients and their caregivers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03530969
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for GI Cancer
Currently open trials in the same condition.
- NCT05804331 — The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study · recruiting
- NCT06040801 — Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Che · NA · recruiting
- NCT05142033 — Avera Cancer Sequencing and Analytics Protocol (ASAP) · recruiting
Other Memorial Sloan Kettering Cancer Center trials
Trials by the same sponsor.
- NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
- NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
- NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer · Phase 2 · recruiting
- NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term · Phase 2 · recruiting
- NCT07449195 — A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03530969 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
- Last refreshed: 20 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03530969.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing